We are a specialty pharmaceutical research company that uses an innovative platform technology to reduce the cost of ophthalmic drug development.

Our 3D-human tissue models support a wide variety of tissue types and measurements of various endpoints. We provide testing and screening services for pharmaceutical and biotech companies along the entire drug development pipeline, to help get a “go or no-go” answer quickly and reliably for preclinical candidates.

We currently have models for glaucoma, and a new model for the blood retinal barrier.

We operate our laboratories located at the SUNY Polytechnic Institute-Albany, NY campus. 

KEY FEATURES OF OUR PROPRIETARY 3D TISSUE SYSTEM:

• Innovative ex vivo-like human tissue screening platform

• High-throughput bio-mimetic perfusion system that provides physiologically relevant data (intraocular pressure/outflow facility)

• Compatible with in vitro bioanalyses (ELISA, qPCR, western blot, etc)

Benefits to using our services:

• Reducing R&D expenditure

• Characterization and validation of drug candidates in species and disease relevant models

• Increased confidence in clinical trial success